Free Trial

10 Best Small Cap Stocks to Buy Now - 10 of 10

 
 

GeoVax Labs (NASDAQ:GOVX)

Consensus Rating
Buy
Rating Score
3.4
Ratings Breakdown
5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$12.67 (530.2% Upside)

About GeoVax Labs

GeoVax Labs logoGeoVax Labs, Inc, a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
8/19/2024Noble FinancialBoost Price TargetOutperform ➝ Outperform$6.00 ➝ $10.00
8/12/2024HC WainwrightReiterated RatingBuy ➝ Buy$8.00 ➝ $8.00
7/23/2024EF Hutton Acquisition Co. IUpgradeStrong-Buy
7/16/2024Roth CapitalUpgradeStrong-Buy
7/16/2024Roth MkmInitiated CoverageBuy$20.00
7/2/2024HC WainwrightReiterated RatingBuy ➝ Buy$8.00 ➝ $8.00
6/18/2024HC WainwrightBoost Price TargetBuy ➝ Buy$8.00 ➝ $120.00
11/13/2023HC WainwrightReiterated RatingBuy ➝ Buy$120.00
10/9/2023HC WainwrightReiterated RatingBuy ➝ Buy$120.00
8/31/2023HC WainwrightReiterated RatingBuy ➝ Buy$120.00

More Investing Slideshows:

 

Tim Sykes’ Urgent Trade Alert: “Make this move now” (Ad)

WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…

Click here to see a unique election-year trade